KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
Open Access
- 30 September 2023
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 24 (1) , 1-9
Abstract
Background: Idiopathic pulmonary fibrosis (IPF) has an unknown aetiology and limited treatment options. A recent meta-analysis identified three novel causal variants in the TERT, SPDL1, and KIF15 genes. This observational study aimed to investigate whether the aforementioned variants cause clinical phenotypes in a well-characterised IPF cohort. Methods: The study consisted of 138 patients with IPF who were diagnosed and treated at the Helsinki University Hospital and genotyped in the FinnGen FinnIPF study. Data on > 25 clinical parameters were collected by two pulmonologists who were blinded to the genetic data for patients with TERT loss of function and missense variants, SPDL1 and KIF15 missense variants, and a MUC5B variant commonly present in patients with IPF, or no variants were separately analysed. Results: The KIF15 missense variant is associated with the early onset of the disease, leading to progression to early-age transplantation or death. In patients with the KIF15 variant, the median age at diagnosis was 54.0 years (36.5–69.5 years) compared with 72.0 years (65.8–75.3 years) in the other patients (P = 0.023). The proportion of KIF15 variant carriers was 9- or 3.6-fold higher in patients aged < 55 or 65 years, respectively. The variants for TERT and MUC5B had similar effects on the patient’s clinical course, as previously described. No distinct phenotypes were observed in patients with the SPDL1 variant. Conclusions: Our study indicated the potential of KIF15 to be used in the genetic diagnostics of IPF. Further studies are needed to elucidate the biological mechanisms of KIF15 in IPF.Keywords
Funding Information
- Research Council of Finland
- Hengityssairauksien Tutkimussäätiö
- Tampereen Tuberkuloosisäätiö
- Nummela sanatorium
- Helsinki University Hospital funds
- The Finnish TB foundation
- Boehringer Ingelheim Fonds
- University of Helsinki including Helsinki University Central Hospital
This publication has 29 references indexed in Scilit:
- Short telomere length in IPF lung associates with fibrotic lesions and predicts survivalPLOS ONE, 2017
- Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and TreatmentFrontiers in Medicine, 2017
- Management of suspected monogenic lung fibrosis in a specialised centreEuropean Respiratory Review, 2017
- Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosisBMC Pulmonary Medicine, 2015
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11The Lancet Respiratory Medicine, 2014
- Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypesTranslational Research, 2014
- Reconstruction of an Integrated Genome-Scale Co-Expression Network Reveals Key Modules Involved in Lung AdenocarcinomaPLOS ONE, 2013
- Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary FibrosisJAMA, 2013
- Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosisNature Genetics, 2013
- Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisThorax, 2013